"Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis." Neurology - Neuroimmunology Neuroinflammation
10.2
(2023):
e200083.
Web. 03 Dec. 2023.
Advertisement
A peer-reviewed clinical and translational neurology open access journal
